IFNG and cancer: By increasing intracellular IFN-γ and reducing PD-1 expression, blocking the IL-4 pathway promotes CD8+ T-cell cytotoxicity, thus sensitizing BCCs to anti-cancer therapy and enhancing the immune responses107.